Iceland· IS-EU/1/18/1272/001 -002
Shingrix
A zoster, gereinigtes antigen product containing recombinant varicella zoster virus surface glycoprotein e, registered in Iceland by GlaxoSmithKline Biologicals S.A.*. The same ATC class is registered in 10 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Zoster, gereinigtes antigen is registered in 10 of 19 countries.
Countries holding a registration under ATC J07BK03 (zoster, gereinigtes antigen), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 7 of them publish a price we can compare per daily dose
Zoster, gereinigtes antigen · ATC J07BK03
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Recombinant varicella zoster virus surface glycoprotein E
- Manufacturer
- GlaxoSmithKline Biologicals S.A.*
- Country
- Iceland (IS)
- ATC code
- J07BK03
- ATC class
- Zoster, gereinigtes Antigen
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 2
2 priced- ean1769470,5 ml x1 hglISK 31485
- ean9870260,5 ml x1 hglISK 64956
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BK03
Zoster, gereinigtes antigen, as other registers publish it.
- NorwayShingrixGlaxoSmithKline Biologicals SA
- FinlandShingrixGlaxoSmithKline Biologicals SA
- DenmarkShingrixGlaxoSmithKline Biologicals
- BelgiumShingrixGlaxoSmithKline Biologicals
- PolandShingrixGlaxoSmithKline Biologicals S.A.
- IcelandShingrixGlaxoSmithKline Biologicals S.A.*
- FinlandShingrixGlaxoSmithKline Biologicals SA
- DenmarkShingrixGlaxoSmithKline Biologicals
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7cc0c8e9-2afc-4bac-91e3-ca7f127b7163 GET /v1/drugs/7cc0c8e9-2afc-4bac-91e3-ca7f127b7163?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stungulyfsstofn og dreifa, dreifa",
"source": "lyfjastofnun",
"atc_raw": "J07BK03",
"marketed": true,
"strength": null,
"ma_number": "EU/1/18/1272/001 -002",
"substance": "Recombinant varicella zoster virus surface glycoprotein E",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "43180"
}See everything about zoster, gereinigtes antigen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.